HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops ...

Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

The new study, published in The Lancet, is the first to evaluate a once-yearly injection of an HIV pre-exposure prophylaxis ...

It’s a tapu subject,” said Milly Stewart, a specialist indigenous service provider pushing for more public education around ...

The spread of the HIV virus in Jayapura has raised concerns amid the high case numbers, with 8,864 cases concentrated in the ...